JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited JBCHEPHARM.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JBCHEPHARM.NS PEL.NS AJANTPHARM.BO AJANTPHARM.NS PPLPHARMA.BO LALPATHLAB.NS ERIS.NS PFIZER.NS LALPATHLAB.BO ERIS.BO
6M 2.10 % 9.10 % -8.57 % -8.75 % -12.22 % 13.55 % 13.30 % 25.78 % 13.61 % 13.42 %
YTD -9.98 % 2.70 % -18.28 % -18.26 % -23.65 % 2.73 % 19.09 % 0.83 % 2.97 % 19.10 %
1Y -11.03 % 9.61 % -17.60 % -17.79 % -8.39 % -5.24 % 24.56 % -2.76 % -5.39 % 24.27 %
3Y 70.78 % 33.43 % 97.65 % 97.10 % 21.21 % 22.95 % 115.57 % 23.08 % 23.04 % 115.10 %
5Y 64.50 % 55.43 % 124.53 % 125.54 % 5.25 % 41.03 % 217.51 % 5.71 % 40.76 % 210.94 %
10Y 468.26 % 114.64 % 135.82 % 135.19 % 5.25 % 280.16 % 163.59 % 112.75 % 280.85 % 163.84 %
From the beginning 7 309.29 % 4 306.90 % 15 236.56 % 15 529.63 % 5.25 % 280.16 % 163.59 % 2 644.36 % 280.85 % 163.84 %

Dividend

J. B. Chemicals & Pharmaceuticals Limited

Piramal Enterprises Limited

Ajanta Pharma Limited

Ajanta Pharma Limited

Piramal Pharma Limited

Dr. Lal PathLabs Limited

Eris Lifesciences Limited

Pfizer Limited

Dr. Lal PathLabs Limited

Eris Lifesciences Limited